Moderate to Severe Rosacea Study
Rosacea Trials in Columbus
Centricity Research is currently participating in a moderate to severe papulopustular rosacea study at our Dublin, Ohio location. Around 16 million Americans have rosacea and a large portion of these people aren’t being treated for it.
Moderate to Severe Papulopustular Rosacea Study
The primary objective of this clinical trial is to evaluate the safety, effectiveness, and tolerability of an oral investigational drug against a placebo in the treatment of moderate to severe papulopustular rosacea in adults. You may be eligible to participate if you:
- Are at least 18 years old
- Have been diagnosed with stage 3 or stage 4 papulopustular rosacea
- Have 15 to 60 inflammatory lesions of rosacea over the face
Ready to Volunteer?
Volunteer today to see if you qualify for our papulopustular rosacea clinical research study. Qualified volunteers may be compensated for time and travel.